Kaliumiodid axapharm 65 mg
Kaliumiodid axapharm 65 mg is a medicine authorised by Swissmedic under authorisation number 67017. The authorisation holder is axapharm ag. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 15 March 2019 and the authorisation is valid without a time limit. ATC code V03AB21 places the medicine in the group All other therapeutic products.
| Authorisation number | 67017 |
|---|---|
| Name | Kaliumiodid axapharm 65 mg |
| Full name | Kaliumiodid axapharm 65 mg, Tabletten |
| Authorisation holder | axapharm ag |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | V03AB21 |
| First authorisation | 15 March 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Kaliumiodid axapharm 65 mg, Tabletten | D | 15 March 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | V03AB21 | 15.03.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Kaliumiodid axapharm 65 mg authorised in Switzerland?
Yes. Kaliumiodid axapharm 65 mg is authorised by Swissmedic under authorisation number 67017, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Kaliumiodid axapharm 65 mg have?
Kaliumiodid axapharm 65 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Kaliumiodid axapharm 65 mg?
The authorisation holder is axapharm ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.